Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice

GLIA

Volumn 62, Issue 5, 2014, Pages 804-817

  Zhang, Xing Mei ^a   Lund, Harald ^a   Mia, Sohel ^a   Parsa, Roham ^a   Harris, Robert A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell therapy; EAE; Macrophages; Microglia; Phenotype

Indexed keywords

CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE; PALLADIUM; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL THERAPY; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MICROGLIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; COCULTURE; DBA MOUSE; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMAN; IMMUNOLOGY; PROCEDURES; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; COCULTURE TECHNIQUES; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNOMODULATION; MICE; MICE, INBRED DBA; MICROGLIA;

EID: 84896313695     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22643     Document Type: Article

References (45)

1. Abdul-Majid KB, Wefer J, Stadelmann C, Stefferl A, Lassmann H, Olsson T, Harris RA. 2003. Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4-/- and CD8-/- DBA/1 mice defines qualitative roles of different T cell subsets. J Neuroimmunol 141:10-19.
2. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14:1142-1149.
3. Almolda B, Gonzalez B, Castellano B. 2011. Antigen presentation in EAE: Role of microglia, macrophages and dendritic cells. Front Biosci 16:1157-1171.
4. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153:4349-4356.
5. Andersson A, Kokkola R, Wefer J, Erlandsson-Harris H, Harris RA. 2004. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J Leukoc Biol 76:1118-1124.
6. Anlar O. 2009. Treatment of multiple sclerosis. CNS Neurol Disord Drug Targets 8:167-174.
7. Auletta JJ, Bartholomew AM, Maziarz RT, Deans RJ, Miller RH, Lazarus HM, Cohen JA. 2012. The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Immunotherapy 4:529-547.
8. Burman J, Fransson M, Totterman TH, Fagius J, Mangsbo SM, Loskog AS. 2013. T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis. Immunology 140:211-219.
9. Crain JM, Nikodemova M, Watters JJ. 2013. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res 91:1143-1151.
10. Czepiel M, Balasubramaniyan V, Schaafsma W, Stancic M, Mikkers H, Huisman C, Boddeke E, Copray S. 2011. Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Glia 59:882-892.
11. Danielyan L, Schafer R, von Ameln-Mayerhofer A, Bernhard F, Verleysdonk S, Buadze M, Lourhmati A, Klopfer T, Schaumann F, Schmid B, Koehle C, Proksch B, Weissert R, Reichardt HM, van den Brandt J, Buniatian GH, Schwab M, Gleiter CH, Frey II WH. 2011. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 14:3-16.
12. Fransson M, Piras E, Burman J, Nilsson B, Essand M, Lu B, Harris RA, Magnusson PU, Brittebo E, Loskog AS. 2012. CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. J Neuroinflammation 9:112.
13. Hanisch UK. 2013. Functional diversity of microglia-How heterogeneous are they to begin with? Front Cell Neurosci 7:65.
14. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hovelmeyer N, Waisman A, Rulicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11:146-152.
15. Hino M, Ogata T, Morino T, Horiuchi H, Yamamoto H. 2009. Intrathecal transplantation of autologous macrophages genetically modified to secrete proenkephalin ameliorated hyperalgesia and allodynia following peripheral nerve injury in rats. Neurosci Res 64:56-62.
16. Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Reuling IE, Polman CH. 2004. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 63:335-339.
17. Jiang Y, Zhu J, Xu G, Liu X. 2011. Intranasal delivery of stem cells to the brain. Expert Opin Drug Deliv 8:623-632.
18. Jones JL, Coles AJ. 2010. New treatment strategies in multiple sclerosis. Exp Neurol 225:34-39.
19. King IL, Dickendesher TL, Segal BM. 2009. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113:3190-3197.
20. Lammertse DP, Jones LA, Charlifue SB, Kirshblum SC, Apple DF, Ragnarsson KT, Falci SP, Heary RF, Choudhri TF, Jenkins AL, Betz RR, Poonian D, Cuthbert JP, Jha A, Snyder DA, Knoller N. 2012. Autologous incubated macrophage therapy in acute, complete spinal cord injury: Results of the phase 2 randomized controlled multicenter trial. Spinal Cord 50:661-671.
21. Mahnke K, Ring S, Bedke T, Karakhanova S, Enk AH. 2008. Interaction of regulatory T cells with antigen-presenting cells in health and disease. Chem Immunol Allergy 94:29-39.
22. Mantia-Smaldone GM, Chu CS. 2013. A review of dendritic cell therapy for cancer: Progress and challenges. BioDrugs 27:453-468.
23. Martinez FO, Sica A, Mantovani A, Locati M. 2008. Macrophage activation and polarization. Front Biosci 13:453-461.
24. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G, Brochet B, Canron MH, Franconi JM, Boiziau C, Petry KG. 2011. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 17:2-15.
25. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
26. Moussaud S, Draheim HJ. 2010. A new method to isolate microglia from adult mice and culture them for an extended period of time. J Neurosci Methods 187:243-253.
27. Murphy AC, Lalor SJ, Lynch MA, Mills KH. 2010. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24:641-651.
28. Murray PJ, Wynn TA. 2011. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723-737.
29. Napoli I, Kierdorf K, Neumann H. 2009. Microglial precursors derived from mouse embryonic stem cells. Glia 57:1660-1671.
30. Owens T, Sriram S. 1995. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol Clin 13:51-73.
31. Parsa R, Andresen P, Gillett A, Mia S, Zhang XM, Mayans S, Holmberg D, Harris RA. 2012. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 61:2881-2892.
32. Ponomarev ED, Shriver LP, Maresz K, Dittel BN. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81:374-389.
33. Pozzilli C, Prosperini L. 2008. Clinical markers of therapeutic response to disease modifying drugs. Neurol Sci 29 (Suppl 2):S211-S213.
34. Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. 2008. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci USA 105:18889-18894.
35. Ranganathan PV, Jayakumar C, Ramesh G. 2013. Netrin-1-treated macrophages protect the kidney against ischemia-reperfusion injury and suppress inflammation by inducing M2 polarization. Am J Physiol Renal Physiol 304:F948-F957.
36. Ransohoff RM, Cardona AE. 2010. The myeloid cells of the central nervous system parenchyma. Nature 468:253-262.
37. Rasmussen S, Imitola J, Ayuso-Sacido A, Wang Y, Starossom SC, Kivisakk P, Zhu B, Meyer M, Bronson RT, Garcia-Verdugo JM, Khoury SJ. 2011. Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol 69:878-891.
38. Saijo K, Glass CK. 2011. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775-787.
39. Scheffel J, Regen T, Van Rossum D, Seifert S, Ribes S, Nau R, Parsa R, Harris RA, Boddeke HW, Chuang HN, Pukrop T, Wessels JT, Jürgens T, Merkler D, Brück W, Schnaars M, Simons M, Kettenmann H, Hanisch UK. 2012. Toll-like receptor activation reveals developmental reorganization and unmasks responder subsets of microglia. Glia 60:1930-1943.
40. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 14:337-342.
41. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. 2007. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 104:19446-19451.
42. Wallberg M, Harris RA. 2005. Co-infection with Trypanosoma brucei brucei prevents experimental autoimmune encephalomyelitis in DBA/1 mice through induction of suppressor APCs. Int Immunol 17:721-728.
43. Wallberg M, Wefer J, Harris RA. 2003. Vaccination with myelin oligodendrocyte glycoprotein adsorbed to alum effectively protects DBA/1 mice from experimental autoimmune encephalomyelitis. Eur J Immunol 33:1539-1547.
44. Weischenfeldt J, Porse B. 2008. Bone marrow-derived macrophages (BMM): Isolation and applications. CSH Protoc 2008:pdb prot5080.
45. Weisser SB, McLarren KW, Kuroda E, Sly LM. 2013. Generation and characterization of murine alternatively activated macrophages. Methods Mol Biol 946:225-239.